SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
Form 10-Q
(Mark One)
| x | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. |
For the quarterly period ended March 31, 2004.
| ¨ | TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. |
For the transition period from to
Commission file number: 000-22302
ISCO INTERNATIONAL, INC.
(Name of Registrant as Specified in Its Charter)
| Delaware | 36-3688459 | |
| (State or Other Jurisdiction of Incorporation or Organization) |
(I.R.S. Employer Identification No.) | |
| 451 Kingston Court Mt. Prospect, Illinois | 60056 | |
| (Address of Principal Executive Offices) | (Zip Code) | |
(847) 391-9400
(Registrants Telephone Number, Including Area Code)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨
Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No x
Indicate the number of shares outstanding of each of the issuers classes of common stock, as of the latest practicable date.
| Class |
Outstanding at April 30, 2004 | |
| Common Stock, par value $0.001 per share Preferred Stock Purchase Rights |
160,428,260 |
| 1 | ||||
| Item 1. Financial Statements. |
1 | |||
| Item 2. Managements Discussion and Analysis of Financial Conditions and Results of Operations. |
9 | |||
| Item 3. Quantitative and Qualitative Disclosures About Market Risk. |
12 | |||
| Item 4. Controls and Procedures. |
12 | |||
| 13 | ||||
| Item 1. Legal Proceedings. |
13 | |||
| Item 2. Changes in Securities, Use of Proceeds and Issuer Purchases of Equity Securities. |
14 | |||
| Item 5. Other Information. |
14 | |||
| 15 | ||||
ISCO INTERNATIONAL, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
| March 31, 2004 |
December 31, 2003 |
|||||||
| (unaudited) | ||||||||
| Assets: |
||||||||
| Current Assets: |
||||||||
| Cash and cash equivalents |
$ | 1,179,458 | $ | 346,409 | ||||
| Inventories |
938,139 | 678,361 | ||||||
| Accounts receivable, net |
210,082 | 1,169,711 | ||||||
| Prepaid expenses and other |
282,474 | 321,147 | ||||||
| Total current assets |
2,610,153 | 2,515,628 | ||||||
| Property and equipment: |
||||||||
| Property and equipment |
8,973,977 | 8,957,866 | ||||||
| Less: accumulated depreciation |
(8,453,660 | ) | (8,256,489 | ) | ||||
| Net property and equipment |
520,317 | 701,377 | ||||||
| Restricted certificates of deposit |
40,527 | 40,527 | ||||||
| Intangible assets, net |
14,466,531 | 14,465,503 | ||||||
| Total assets |
$ | 17,637,528 | $ | 17,723,035 | ||||
| Liabilities and Stockholders Equity: |
||||||||
| Current liabilities: |
||||||||
| Accounts payable |
$ | 102,376 | $ | 243,647 | ||||
| Accrued liabilities |
1,212,593 | 1,536,141 | ||||||
| Total current liabilities |
1,314,969 | 1,779,788 | ||||||
| Other long-term debt, less current portion |
5,000,000 | 5,000,000 | ||||||
| Stockholders equity: |
||||||||
| Preferred stock; 300,000 shares authorized; No shares issued and outstanding at March 31, 2004 and December 31, 2003 |
| | ||||||
| Common stock ($.001 par value); 250,000,000 shares authorized; 160,410,760 and 150,149,927 shares issued and outstanding at March 31, 2004 and December 31, 2003, respectively |
160,411 | 150,150 | ||||||
| Additional paid-in capital (net of unearned compensation) |
163,215,910 | 160,889,202 | ||||||
| Accumulated deficit |
(152,053,762 | ) | (150,096,105 | ) | ||||
| Total stockholders equity |
11,322,559 | 10,943,247 | ||||||
| Total liabilities and stockholders equity |
$ | 17,637,528 | $ | 17,723,035 | ||||
NOTE: The condensed consolidated balance sheet as of December 31, 2003 has been derived from the audited financial statements for that date, but does not include all of the information and accompanying notes required by accounting principles generally accepted in the United States of America for complete financial statements.
See the accompanying Notes which are an integral part of the Condensed Consolidated Financial Statements.
1
ISCO INTERNATIONAL, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(UNAUDITED)
| Three Months Ended March 31, |
||||||||
| 2004 |
2003 |
|||||||
| Net sales |
$ | 421,950 | $ | 1,235,351 | ||||
| Costs and expenses: |
||||||||
| Cost of sales |
308,595 | 629,521 | ||||||
| Research and development |
233,989 | 289,713 | ||||||
| Selling and marketing |
223,539 | 273,733 | ||||||
| General and administrative |
1,233,550 | 2,928,659 | ||||||
| Total costs and expenses |
1,999,673 | 4,121,626 | ||||||
| Operating loss |
(1,577,723 | ) | (2,886,275 | ) | ||||
| Other income (expense): |
||||||||
| Interest income |
1,807 | 2,056 | ||||||
| Non-cash interest expense |
(250,297 | ) | (212,516 | ) | ||||
| Interest expense |
(131,445 | ) | (54,361 | ) | ||||
| (379,935 | ) | (264,820 | ) | |||||
| Net loss |
$ | (1,957,658 | ) | $ | (3,151,095 | ) | ||
| Basic and diluted loss per share |
$ | (0.01 | ) | $ | (0.02 | ) | ||
| Weighted average number of common shares outstanding |
154,233,040 | 147,956,594 | ||||||
See the accompanying Notes which are an integral part of the Condensed Consolidated Financial Statements.
2
ISCO INTERNATIONAL, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(UNAUDITED)
| Three Months Ended March 31, |
||||||||
| 2004 |
2003 |
|||||||
| Operating Activities: |
||||||||
| Net loss |
$ | (1,957,658 | ) | $ | (3,151,095 | ) | ||
| Adjustments to reconcile net loss to net cash used in operating activities: |
||||||||
| Depreciation and amortization |
209,373 | 196,959 | ||||||
| Non-cash interest (warrant) expense |
250,297 | 212,516 | ||||||
| Non-cash compensation expense |
48,705 | 413,050 | ||||||
| Changes in operating assets and liabilities |
273,706 | 1,627,858 | ||||||
| Net cash used in operating activities |
(1,175,577 | ) | (700,712 | ) | ||||
| Investing Activities: |
||||||||
| Decrease/(Increase) in restricted certificates of deposit |
| 24,050 | ||||||
| Payment of patent costs |
(13,231 | ) | (31,957 | ) | ||||
| Acquisition of property and equipment |
(16,111 | ) | (6,101 | ) | ||||
| Net cash used in investing activities |
(29,341 | ) | (1,806 | ) | ||||
| Financing Activities: |
||||||||
| Exercise of warrants |
2,000,000 | | ||||||
| Proceeds from short-term loan |
| 1,000,000 | ||||||
| Exercise of stock options |
37,967 | | ||||||
| Net cash provided by financing activities |
2,037,967 | 1,000,000 | ||||||
| Increase in cash and cash equivalents |
833,049 | 297,482 | ||||||
| Cash and cash equivalents at beginning of period |
346,409 | 216,119 | ||||||
| Cash and cash equivalents at end of period |
$ | 1,179,458 | $ | 513,601 | ||||
See the accompanying Notes which are an integral part of the Condensed Consolidated Financial Statements.
3
ISCO INTERNATIONAL, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
Note 1 - Basis of Presentation
The condensed consolidated financial statements include the accounts of ISCO International, Inc. and its wholly-owned subsidiaries, Spectral Solutions, Inc. and Illinois Superconductor Canada Corporation (collectively referred to as the Company). All significant intercompany balances and transactions have been eliminated in consolidation.
The accompanying unaudited condensed consolidated financial statements have been prepared by the Company in accordance with accounting principles generally accepted in the United States of America (US GAAP) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by US GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation of results for the interim periods have been included. These financial statements and notes included herein should be read in conjunction with the Companys audited financial statements and notes for the year ended December 31, 2003 included in the Companys Annual Report on Form 10-K filed with the Securities and Exchange Commission. The results of operations for the interim periods presented are not necessarily indicative of the results to be expected for any subsequent quarter of for the entire year ending December 31, 2004. For further information, refer to the financial statements, including the notes thereto, included in the Companys Annual Report on Form 10-K for the fiscal year ended December 31, 2003.
Recent Accounting Pronouncements
In January 2003, the FASB issued FASB Interpretation No. 46 (FIN No. 46), Consolidation of Variable Interest Entities, to expand upon existing accounting guidance that addresses when a company should include in its financial statements the assets, liabilities and activities of another entity. In December 2003, the FASB revised FIN No. 46 to provide more clarification. Until now, a company generally has included another entity in its consolidated financial statements only if it controlled the entity through voting interests. FIN No. 46 changes that by requiring a variable interest entity, as defined, to be consolidated by a company if that company is subject to a majority of the risk of loss from the variable interest entitys activities or entitled to receive a majority of the entitys residual returns or both. FIN No. 46, as revised, did not have a material impact on the Companys consolidated financial statements.
Note 2. Realization of Assets
The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America, which contemplate continuation of the Company as a going concern. However, the Company has sustained substantial losses from operations in recent years, and such losses have continued through the (unaudited) quarter ended March 31, 2004. In addition, the Company has used, rather than provided, cash in its operations.
In view of the matters described in the preceding paragraph, recoverability of a major portion of the recorded asset amounts shown in the accompanying balance sheet is dependent upon continued operations of the Company, which in turn is dependent upon the Companys ability to meet its operational
4
and financing requirements on a continuing basis, to maintain present financing, and to succeed in its future operations. The financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or amounts and classification of liabilities that might be necessary should the Company be unable to continue in existence.
The Company has incurred, and continues to incur, losses from operations. For the years ended December 31, 2003, 2002, and 2001, the Company incurred net losses of $7,156,075, $13,077,832, and $28,189,603, respectively. The Company incurred an additional net loss of $1,957,658 during the first three months of 2004. During the past few years the Company implemented strategies to reduce its cash used in operating activities. The Companys strategy included the consolidation of its manufacturing and research and development facilities and a targeted reduction of the employee workforce, increasing the efficiency of the Companys processes, focusing development efforts on products with a greater probability of commercial sales, expanding its outsourcing of manufacturing strategy, reducing professional fees and discretionary expenditures, and negotiating favorable payment arrangements with suppliers and service providers.
To date, the Company has financed its operations primarily through public and private equity and debt financings. Subject to the uncommitted nature of the credit line, the Company believes that it has sufficient funds to operate its business as identified herein and to meet its obligations through 2004, provided that the Company is able to borrow the $1 million remaining under the uncommitted line of credit. Should this line not be available, the Company believes it has sufficient funds to operate into the third or fourth quarter 2004, and quite possibly beyond, depending on operating results. The Company intends to look into augmenting its existing capital position by utilizing the credit line as identified and/or through other sources of capital.
Note 3 - Net Loss Per Share
Basic and diluted net loss per share is computed based on the weighted average number of common shares outstanding. Common shares issuable upon the exercise of options are not included in the per share calculations since the effect of their inclusion would be antidilutive.
Note 4 - Inventories
Inventories consisted of the following:
| March 31, 2004 |
December 31, 2003 | |||||
| Raw materials |
$ | 268,000 | $ | 357,000 | ||
| Work in process |
310,000 | 67,000 | ||||
| Finished product |
360,000 | 254,000 | ||||
| $ | 938,000 | $ | 678,000 | |||
Cost of product sales for the three months ending March 31, 2004, and the twelve months ending December 31, 2003 include approximately $0 and $130,000, respectively, of costs in excess of the net realizable value of inventory.
Note 5 - Stock Options and Warrants
On August 19, 1993, the Board of Directors adopted the 1993 Stock Option Plan (the Plan) for employees, consultants, and directors who are not also employees of the Company (outside directors). This plan reached its ten-year expiration during 2003. During the 2003 annual meeting of shareholders,
5
the Companys shareholders approved a new 2003 Equity Incentive Plan to take the place of the expiring 1993 plan. Unissued options from the 1993 plan were used to fund the 2003 plan. The maximum number of shares issuable under these plans was 14,011,468.
For employees and consultants, the Plan provides for granting of Incentive Stock Options (ISOs) and Nonstatutory Stock Options (NSOs). In the case of ISOs, the exercise price shall not be less than 100% (110% in certain cases) of the fair value of the Companys common stock, as determined by the Compensation Committee or full Board as appropriate (the Committee), on the date of grant. In the case of NSOs, the exercise price shall be determined by the Committee, on the date of grant. The term of options granted to employees and consultants will be for a period not to exceed 10 years (five years in certain cases). Options granted under the Plan default to vest over a four year period (one-fourth of options granted vest after one year from the grant date and the remaining options vest ratably each month thereafter), but the vesting period is determined by the Committee. In addition, the Committee may authorize option grants with vesting provisions that are not based solely on employees rendering of additional service to the Company.
For outside directors, the Plan provides that each outside director will be automatically granted NSOs on the date of their initial election to the board of directors. On the date of the annual meeting of the stockholders of the Company, each outside director who is elected, reelected, or continues to serve as a director, shall be granted additional NSOs, except for those outside directors who are first elected to the Board of Directors at the meeting or three months prior. The options granted vest ratably over one or two years, based on the date of grant, and expire after ten years from the grant date.
On May 10, 1999, the Board of Directors granted to each employee of the Company (other than the executive officers of the Company) (collectively, the Non-Executive Employees) the option to (i) reduce the exercise prices of up to a maximum of 15,000 of the unexercised stock options previously granted to such Non-Executive Employee under the Plan to $.5625 per share (the closing price of the Companys Common Stock on May 10, 1999) and (ii) cause all of such stock options not otherwise scheduled to become fully vested on or before May 10, 2000 to become fully vested on such date. As a result thereof, an aggregate of 279,550 stock options previously granted under the Plan were amended as described in the preceding sentence. In addition, on May 10, 1999 the Board of Directors granted to the executive officers and certain Non-Executive Employees of the Company additional non-statutory stock options to purchase an aggregate of 343,575 shares of the Companys Common Stock under the Plan. Such stock options became fully vested on the first anniversary of the date of grant, with exercise prices of $.5625 per share and expire 10 years from the date of grant.
On July 1, 2000, Financial Accounting Standards Board Interpretation No. 44, Accounting for Certain Transactions involving Stock Compensation, an interpretation of APB Opinion No. 25 (FIN 44) was adopted by the Company. FIN 44 requires that stock options that have been modified to reduce the exercise price be subject to variable accounting. The Company accounts for employee stock options under APB Opinion No. 25 and non-employee stock options under Statement of Financial Accounting Standards No. 123, Accounting for Stock Based Compensation (SFAS No. 123).
On May 10, 1999, as described above, the Company re-priced certain stock options granted to employees and in accordance with US GAAP, at that time, the Company accounted for the re-priced stock options as fixed. As a result of adopting FIN 44, the Company is required to apply variable accounting to these options. If the market price of the Companys common stock increases above the July 1, 2000 market price, the Company will have to recognize additional compensation expense equal to the increase in stock price multiplied by the number of re-priced options. No additional expense will be recognized if the stock does not exceed the July 1, 2000 value. However, the impact cannot be determined as it is dependent on the change in the market price of the common stock from July 1, 2000 until the stock options are exercised, forfeited, or expire unexercised. Because the stock price on December 31, 2003 was below that of July 1, 2000, no expense has been recognized during the period.
6
On February 5, 2001, the Companys board of directors authorized the re-pricing of certain out of the money stock options granted to employees during the calendar year of 2000 to the closing share price on such date, or $1.9375 per share. This re-pricing causes these options to be subject to variable accounting as described in FIN 44. Because the stock price on March 31, 2004, was lower than the re-priced strike price no gain or loss was recognized during the period.
On April 1, 2002, the Companys board of directors authorized the re-pricing of certain out of the money stock options granted to employees. A new strike price of $0.81 per share was established, provided the respective employees remain with the Company for at least six months following the re-pricing date. In addition, certain stock options granted to directors were repriced, with a new strike price of $1.00 per share. As the stock price on March 31, 2004, was lower than the re-priced strike price no gain or loss was recognized during the period.
On February 15, 2002, the Company completed a Shareholder Rights Offering. Approximately $20 million was raised from existing shareholders as of the recording date in exchange for the issuance of approximately 40 million shares of the Companys common stock. A portion of the proceeds were then used to repay in full $9.8 million of debt and related accrued interest, as well as the payment of various other accrued expenses.
On October 31, 2003, the Companys board of directors authorized the re-pricing of certain out of the money stock options granted to directors. A new strike price of $0.24 per share was established. This price was based on the closing price of the Companys common stock as quoted on the American Stock Exchange on October 1, 2003. The closing price of the Companys common stock on October 31, 2003 was $0.20 per share.
During 2003, the Companys Board of Directors granted 3,570,000 new stock options to the Companys employees, including officers, and Directors. The majority of the grants to employees, including officers, were priced at 25% of the average closing price of the Companys common stock as reported on the American Stock Exchange over ten trading days prior to the date of grant. Due to the resulting discount, $217,000 of compensation expense was recognized during the first quarter of 2004.
Certain options granted prior to 2004 were deemed subject to variable accounting. As such, a charge of $418,000 was recognized during the fourth quarter 2003 to reflect the $0.55 closing price of the Companys common stock as of December 31, 2003. Because the closing price of the Companys common stock on March 31, 2004 was $0.44 per share, $168,000 of this amount was reversed during the first quarter 2004. During July 2003, the Board of Directors cancelled approximately 2.8 million outstanding options held by certain Company employees, including officers.
During the first three months of 2004, the Companys board of directors granted 3,710,000 stock options to the Companys employees and non-employee Board members. The options granted to non-employee directors were issued at the closing market price on the date of grant. The majority of the option grants were to employees and were issued at a discount to market price based on 25% of the average closing price of the Companys common stock as reported on the American Stock Exchange for ten trading days.
7
Note 6 Debt
As of the reporting date, the Company had drawn $5 million of debt financing under a credit line, as described below. During October 2002, the Company entered into an Uncommitted Line of Credit with its two largest shareholders, an affiliate of Elliott Associates, L.P. (Manchester Securities Corporation) and Alexander Finance, L.P. This line provided up to $4 million to the Company. This line was uncommitted, such that each new borrowing under the facility would be subject to the approval of the lenders. Borrowings on this line bore an interest rate of 9.5% and are collateralized by all the assets of the Company. Outstanding loans under this agreement would be required to be repaid on a priority basis should the Company receive new funding from other sources. Additionally, the lenders were entitled to receive warrants to the extent funds were drawn down on the line. The warrants bore a strike price of $0.20 per share of common stock and were to expire on April 15, 2004. The credit line was to mature and be due, including accrued interest thereon, on March 31, 2004. Due to an agreement between the parties that did not provide warrants with respect to the most recent $2 million in borrowings, a maximum of 10 million warrants were issued as a result of this transaction. During February 2004, the warrant holders exercised all of their warrants, contributing $2 million to the Company in exchange for 10 million shares of common stock.
According to existing accounting pronouncements and SEC guidelines, the Company has allocated the proceeds of these borrowings between their debt and equity components. As a result of these borrowings during 2002, the Company has recorded a non-cash charge of $1.2 million through the outstanding term of the warrants (fully exercised as of March 31, 2004). The final $250,000 of that amount was recorded during the quarter ended March 31, 2004.
As announced during October 2003, the Company entered into an agreement with its lenders to supplement the credit line with an additional $2 million, $1 million of which was drawn immediately and $1 million available to be drawn upon the Companys request and subject to the approval of the lenders. This supplemental facility bore a 14% rate of interest and was due October 31, 2004. Unlike the previous credit line, the supplemental facility did not include any stock warrants. The term of the previous credit line were not affected by this supplement, and as such the $4 million borrowed under that line, plus accrued interest, remained due March 31, 2004.
During February 2004, these credit lines were extended to a due date of April 2005, with interest after the initial periods to be charged at 14%. No warrants or other inducements were issued with respect to these extensions. Additionally, as noted above, the lenders exercised their 10 million warrants during February 2004, agreeing to let the Company use the funds for general purposes as opposed to repaying debt.
Note 7 Stock Based Compensation
The Company has a stock-based employee compensation plan, which is more fully described in Note 5. The Company accounts for its stock-based compensation plan under Statement of Financial Accounting Standards (SFAS) No. 123, Accounting for Stock-Based Compensation, as amended by SFAS No. 148, Accounting for Stock-Based Compensation-Transition and Disclosure, which allows companies to apply the provisions of Accounting Principles Board (APB) Opinion No. 25, Accounting for Stock Issued to Employees, and provide pro forma net income and net income per share disclosures for employee stock option grants as if the fair value method defined in SFAS No. 123 had been applied. The Company applies the intrinsic value method for accounting for stock-based compensation as outlined in APB Opinion No. 25.
Stock expense for the first quarters of 2004 and 2003, respectively, includes the result of options issued with an exercise price below the underlying stocks market price. The following table illustrates
8
the effect on net income and earnings per share if the Company had applied the fair value recognition provisions of FASB Statement 123, Accounting for Stock-Based Compensation as amended by SFAS No. 148, Accounting for Stock-Based CompensationTransition and Disclosurean amendment of FASB Statement No. 123, using the assumptions described in Note 5, to its stock-based employee plans:
| Quarter Ended 2004 |
March 31, 2003 | |||||
| Net loss, as reported |
$ | 1,958 | $ | 3,151 | ||
| Add: Stock-based employee compensation expense included in reported net loss, net of related tax effects |
49 | 413 | ||||
| Less: Total stock-based employee compensation determined under fair value based method for awards granted, modified, or settled, net of related tax effects |
142 | 899 | ||||
| Pro forma net loss |
$ | 2,051 | $ | 3,637 | ||
| Loss per share: |
||||||
| Basic as reported |
$ | 0.01 | $ | 0.02 | ||
| Basic pro forma |
$ | 0.01 | $ | 0.02 | ||
| Diluted as reported |
$ | 0.01 | $ | 0.02 | ||
| Diluted pro forma |
$ | 0.01 | $ | 0.02 | ||
Item 2. Managements Discussion and Analysis of Financial Conditions and Results of Operations.
General
The following is a discussion and analysis of the historical results of operations and financial condition of the Company and factors affecting the Companys financial resources. This discussion should be read in conjunction with the financial statements, including the notes thereto, set forth herein under Part I. - Financial Information and Item 1. Financial Statements and in the Companys Annual Report on Form 10-K for the fiscal year ended December 31, 2003. This discussion contains forward-looking statements which involve certain risks, uncertainties and contingencies which could cause the Companys actual results, performance or achievements to differ materially from those expressed, or implied, by such forward-looking statements. Such factors include those described in Risk Factors included in the Companys Annual Report on Form 10-K. The forward-looking statements included in this report may prove to be inaccurate. In light of the significant uncertainties inherent in these forward-looking statements, you should not consider this information to be a guarantee by the Company or any other person that our objectives and plans will be achieved.
The Company provides a wide array of solutions to optimize the reverse link for the wireless telecommunications industry. Reverse link is the signal from the mobile device to the base station. Reverse link problems often